{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Cardio Diagnostics Holdings Inc."},"Symbol":{"label":"Symbol","value":"CDIO"},"Address":{"label":"Address","value":"United States"},"Phone":{"label":"Phone","value":""},"Industry":{"label":"Industry","value":"Biotechnology: In Vitro & In Vivo Diagnostic Substances"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assists in the treatment of cardiovascular disease."},"CompanyUrl":{"label":"Company Url","value":"https://www.cardiodiagnosticsinc.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Meeshanthini V. Dogan","title":"Chief Executive Officer & Director"},{"name":"Robert Philibert","title":"Chief Medical Officer & Director"},{"name":"Timur Dogan","title":"Chief Technology Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}